Cloud Computing in Emerging Biotech and Pharmaceutical Companies

Authors

Thomas Sommer, Quinnipiac University

Abstract

The purpose of this research is to determine the qualitative advantages and disadvantages of cloud computing in emerging biotech and pharmaceutical companies. From the perspective of four small biotech and pharmaceutical organizations the research investigated the positive and negative aspects of cloud computing and how it impacted the way these organizations conduct business in an increasingly complex global community. The research techniques were mixed qualitative methods that provided cross-examination and included action research, observations, interviews, surveys, and case studies. The analysis used triangulation and resulted in the discovery of patterns and themes, which provided separate interpretations and assertions of perceived benefits and obstacles. The research indicated that small biotech and pharmaceutical companies find cloud computing very attractive with some relatively minor drawbacks, which can be mitigated with adequate planning and proper implementation.

Recommended Citation

Sommer, Thomas (2013) "Cloud Computing in Emerging Biotech and Pharmaceutical Companies," Communications of the IIMA: Vol. 13: Iss. 3, Article 3.
DOI: https://doi.org/10.58729/1941-6687.1218
Available at: https://scholarworks.lib.csusb.edu/ciima/vol13/iss3/3